GPT Healthcare Limited Reports Strong Results with 18% Year-on-Year Growth in Q1 FY27
GPT Healthcare Limited (BSE: 544131; NSE: GPTHEALTH) has announced its unaudited financial results for the first quarter of the financial year 2026, which concluded on June 30, 2026. The company reported a Total Income of Rs 128 crore in Q1 FY27, marking an 18% growth compared to the same period in the previous fiscal year.Financial Performance Highlights
The results demonstrate robust performance across key metrics for GPT Healthcare Limited during the quarter. The unaudited figures are detailed below:| Particulars (Rs. Crs) | Q1FY27 | Q1FY26 | Y-o-Y | Q4FY26 | Q-o-Q | FY26 |
|---|---|---|---|---|---|---|
| Total Income | 128.2 | 108.7 | 18.0% | 128.0 | 0.2% | 478.5 |
| EBITDA | 26.2 | 18.9 | 38.5% | 25.0 | 4.9% | 90.1 |
| EBITDA Margin (%) | 20.4% | 17.4% | 19.5% | 18.8% | ||
| Profit After Tax | 12.7 | 7.7 | 65.7% | 14.6 | -12.6% | 42.2 |
| PAT Margin (%) | 9.9% | 7.1% | 11.4% | 8.8% |
Operational Milestones and Network Expansion
The company achieved several key operational milestones across its facilities during Q1 FY27. The ILS brand continued to strengthen its service delivery, focusing on specialized procedures and facility advancements:- Procedural Achievements: ILS Dum Dum successfully completed over 700 renal transplants. ILS Agartala delivered more than 700 radiation therapy procedures. Furthermore, ILS Salt Lake surpassed 800 robotic surgeries.
- Technology Integration: ILS Howrah launched the MAKO system for Robotic Knee Surgery.
- Capacity and Licenses: The Raipur facility received its liver transplant license and is projected to reach break-even status by Q3 FY27. The Jamshedpur hospital remains on schedule for completion by Q4 FY27.
- Market Focus: The company strengthened its clinical research footprint through participation in the BEMAKI acute kidney injury trial.
Occupancy and Market Strategy
The Company maintained a competitive and affordable Average Revenue Per Occupied Bed (ARPOB) at INR 42,350. Occupancy rates showed steady improvement at 58.07% when excluding the newly commenced Raipur facility, driven by efficient capacity utilization and higher patient volumes. When factoring in the Raipur facility, the overall occupancy stands at 45.5%.GPT Healthcare Chairman, Dr. Om Tantia, commented on the quarter’s performance, stating that GPT Healthcare is advancing its long-term growth strategy by improving occupancy across mature hospitals and progressively ramping up newer facilities. The company focused on expanding high-value specialties and introducing services aligned with patient demand, increasing the adoption of robotic-assisted procedures. He added that the firm strengthened its doctor and insurance networks to enhance patient access.
Dr. Tantia noted that, in line with a capital-efficient expansion strategy, the Company is finalizing its seventh hospital, which is anticipated to increase the network’s total capacity to over 1,000 beds. These initiatives are designed to unlock operating leverage and deliver sustainable returns while maintaining the company's net debt-free position.
About GPT Healthcare Limited (GPT)
As the healthcare arm of the GPT Group, GPT Healthcare operates the ILS Hospitals brand, positioning itself as a leading neighbourhood tertiary-care hospital platform in Eastern India. Established in 2000, the network currently encompasses five multi-specialty hospitals: ILS Salt Lake (85 beds), ILS Agartala (205 beds), ILS Dumdum (155 beds), ILS Howrah (116 beds), and ILS Raipur (158 beds). The collective capacity of the network is over 719 beds, strategically located in high-density residential areas across Eastern India.The company employs a proximity-based, capital-efficient operating model, offering advanced tertiary care services including oncology, cardiology, renal transplants, and robotic surgeries, all underpinned by standardized clinical governance and experienced medical leadership.
GPTHEALTH Stock Price Movement
Shares of GPT Healthcare Limited slipped by 4.37% in post-market trading today, settling at ₹163.94 after shedding ₹7.45 from its previous close. The equity traded on a volume of 509,164 shares, having reached an intraday low of ₹163 during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.